|1.||Klaunig, James E: 1 article (08/2012)|
|2.||Stagg, Nicola J: 1 article (08/2012)|
|3.||Gollapudi, B Bhaskar: 1 article (08/2012)|
|4.||LeBaron, Matthew J: 1 article (08/2012)|
|5.||Eisenbrandt, David L: 1 article (08/2012)|
08/01/2012 - "Lifetime rodent feeding studies reported in 1977 with low-purity oxyfluorfen (85%) showed no increase in any tumor type in rats (800 ppm, high dose) and only a marginally increased incidence of hepatocellular tumors in male CD-1 mice at the highest dose (200 ppm). "
08/01/2012 - "Collectively, these data along with the negative genotoxicity demonstrate that oxyfluorfen (> 98% purity) has the potential to induce mouse liver tumors through a nongenotoxic, mitogenic MOA with a clear threshold and is not predicted to be carcinogenic in humans at relevant exposure levels."
|2.||Variegate Porphyria (Protoporphyrinogen Oxidase Deficiency)